Brugada Syndrome (disorder)
|
0.620 |
GeneticVariation
|
disease |
BEFREE |
Human KCNE5 mutations are associated with atrial fibrillation (AF)- and Brugada syndrome (BrS)-induced cardiac arrhythmias that can arise from increased potassium current in cardiomyocytes.
|
30289750 |
2019 |
Brugada Syndrome (disorder)
|
0.620 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
The human AF-associated mutation KCNE5-L65F negative shifted the voltage dependence of K<sub>V</sub>2.1-KCNE5 channels, increasing their maximum current density >2-fold, whereas BrS-associated KCNE5 mutations produced more subtle negative shifts in K<sub>V</sub>2.1 voltage dependence.
|
30289750 |
2019 |
Atrial Fibrillation
|
0.330 |
GeneticVariation
|
disease |
BEFREE |
The human AF-associated mutation KCNE5-L65F negative shifted the voltage dependence of K<sub>V</sub>2.1-KCNE5 channels, increasing their maximum current density >2-fold, whereas BrS-associated KCNE5 mutations produced more subtle negative shifts in K<sub>V</sub>2.1 voltage dependence.
|
30289750 |
2019 |
Atrial Fibrillation
|
0.330 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
The human AF-associated mutation KCNE5-L65F negative shifted the voltage dependence of K<sub>V</sub>2.1-KCNE5 channels, increasing their maximum current density >2-fold, whereas BrS-associated KCNE5 mutations produced more subtle negative shifts in K<sub>V</sub>2.1 voltage dependence.
|
30289750 |
2019 |
Ventricular arrhythmia
|
0.010 |
Biomarker
|
disease |
BEFREE |
Increased K<sub>V</sub> current is a manifestation of KCNE5 disruption that is most likely common to both mouse and human hearts, providing a plausible mechanistic basis for human KCNE5-linked AF and BrS.-David, J.-P., Lisewski, U., Crump, S. M., Jepps, T. A., Bocksteins, E., Wilck, N., Lossie, J., Roepke, T. K., Schmitt, N., Abbott, G. W. Deletion in mice of X-linked, Brugada syndrome- and atrial fibrillation-associated Kcne5 augments ventricular K<sub>V</sub> currents and predisposes to ventricular arrhythmia.
|
30289750 |
2019 |
Premature ventricular contractions
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
Intracardiac ECG revealed that Kcne5 deletion caused ventricular premature beats, increased susceptibility to induction of polymorphic ventricular tachycardia (60 vs. 24% in Kcne5<sup>+/0</sup> mice), and 10% shorter ventricular refractory period.
|
30289750 |
2019 |
Ventricular tachycardia, polymorphic
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Intracardiac ECG revealed that Kcne5 deletion caused ventricular premature beats, increased susceptibility to induction of polymorphic ventricular tachycardia (60 vs. 24% in Kcne5<sup>+/0</sup> mice), and 10% shorter ventricular refractory period.
|
30289750 |
2019 |
Brugada Syndrome (disorder)
|
0.620 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Exome analysis in 34 sudden unexplained death (SUD) victims mainly identified variants in channelopathy-associated genes.
|
29350269 |
2018 |
Atrial Fibrillation
|
0.330 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Exome analysis in 34 sudden unexplained death (SUD) victims mainly identified variants in channelopathy-associated genes.
|
29350269 |
2018 |
Brugada Syndrome (disorder)
|
0.620 |
Biomarker
|
disease |
CLINGEN |
KCNE4 and KCNE5: K(+) channel regulation and cardiac arrhythmogenesis.
|
27484720 |
2016 |
Acute Chest Syndrome
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
This study suggests an association between rs697829, a common single nucleotide polymorphism (SNP) from KCNE5, and ECG measurements and survival in postacute ACS patients.
|
21985337 |
2012 |
Acute Coronary Syndrome
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
KCNE5 polymorphism rs697829 is associated with QT interval and survival in acute coronary syndromes patients.
|
21985337 |
2012 |
Brugada Syndrome (disorder)
|
0.620 |
GeneticVariation
|
disease |
ORPHANET |
In 205 Japanese patients with BrS or IVF who tested negative for SCN5A mutation, we conducted a genetic screen for KCNE5 variants.
|
21493962 |
2011 |
Brugada Syndrome (disorder)
|
0.620 |
Biomarker
|
disease |
CLINGEN |
In 205 Japanese patients with BrS or IVF who tested negative for SCN5A mutation, we conducted a genetic screen for KCNE5 variants.
|
21493962 |
2011 |
Brugada Syndrome (disorder)
|
0.620 |
GeneticVariation
|
disease |
BEFREE |
This study investigated whether KCNE5 mutations could be responsible for BrS and other idiopathic ventricular fibrillation (IVF).
|
21493962 |
2011 |
Paroxysmal familial ventricular fibrillation
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
This study investigated whether KCNE5 mutations could be responsible for BrS and other idiopathic ventricular fibrillation (IVF).
|
21493962 |
2011 |
Ventricular Fibrillation, Paroxysmal Familial, 1
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
This study investigated whether KCNE5 mutations could be responsible for BrS and other idiopathic ventricular fibrillation (IVF).
|
21493962 |
2011 |
Atrial Fibrillation
|
0.330 |
GeneticVariation
|
disease |
BEFREE |
One-hundred fifty-eight patients with AF were screened for mutations in the coding region of KCNE5.
|
18313602 |
2008 |
Atrial Fibrillation
|
0.330 |
GeneticVariation
|
disease |
LHGDN |
One-hundred fifty-eight patients with AF were screened for mutations in the coding region of KCNE5.
|
18313602 |
2008 |
Atrial Fibrillation
|
0.330 |
GeneticVariation
|
disease |
BEFREE |
Because the KCNE5 gene is located on the X chromosome, the protection conferred by the 97T polymorphism may help explain the gender-related difference in the risk of AF.
|
16054468 |
2005 |
Long QT Syndrome
|
0.010 |
Biomarker
|
disease |
BEFREE |
Does KCNE5 play a role in long QT syndrome?
|
15193977 |
2004 |
Brugada Syndrome (disorder)
|
0.620 |
Biomarker
|
disease |
CLINGEN |
KCNE1-like gene is deleted in AMME contiguous gene syndrome: identification and characterization of the human and mouse homologs.
|
10493825 |
1999 |
Congenital Heart Defects
|
0.010 |
Biomarker
|
group |
BEFREE |
The specific distribution in adult tissues, the putative channel function, and the expression pp6tern in the developing mouse embryo suggest that KCNE1L could be involved in the development of the cardiac abnormalities as well as of some neurological signs observed in patients with AMME contiguous gene syndrome.
|
10493825 |
1999 |
Contiguous gene syndrome
|
0.010 |
Biomarker
|
disease |
BEFREE |
The specific distribution in adult tissues, the putative channel function, and the expression pp6tern in the developing mouse embryo suggest that KCNE1L could be involved in the development of the cardiac abnormalities as well as of some neurological signs observed in patients with AMME contiguous gene syndrome.
|
10493825 |
1999 |
Paroxysmal familial ventricular fibrillation
|
0.310 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|